Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ModiQuest Announces Publication of Novel Antibodies

Published: Tuesday, April 23, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
ModiQuest BV announced the publication of novel anti-citrullinated therapeutic antibodies for the treatment of rheumatoid arthritis.

In this publication, ModiQuest describes the discovery of novel therapeutic anti-citrullinated protein antibodies (tACPAs) that prevent the onset and/or exacerbation of inflammation and that prevent or strongly reduce the occurrence of swelling and joint damage, using a collagen antibody-induced arthritis mouse model. The ACPAs discovered by ModiQuest are directed against a citrullinated epitope in histone-2A protein in man and mouse.
 
ModiQuest has made this discovery using its proprietary antibody discovery technology platforms M-Fuse™ (highly efficient hybridoma electrofusion technology), M-Select™ (B-cell selection technology for low immunogenic or multiple antigen targets) and M-Phage™ (proprietary phase display libraries). All three technology platforms are also used by ModiQuest’s service business, ModiQuest Research BV, for custom antibody lead generation in third party service projects.
 
“The novel tACPA leads we have discovered offer a new way to contribute to the treatment of rheumatoid arthritis, and we are today in discussions with a number of pharmaceutical companies to progress the tACPA leads into clinical development”, says Dr. Jos Raats, CEO of ModiQuest. “The discovery of these antibody leads again demonstrates the huge potential of our M-Fuse™, M-Select™ and M-Phage™ technologies for the discovery of novel therapeutic and diagnostic antibodies against low-immunogenic targets.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
Protein Teams Activate T-Cells
Caltech researchers have discovered T-cell genetic switching is controlled by four proteins acting in a multi-tiered fashion.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer
‘Antigen-presenting cell’ activates T cells by alerting them to the presence of tumors.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!